Выпуск №1 за 2020 год
Background. Male infertility is an acute issue in modern andrology, being registered in 45% of infertile couples. Aer the exclusion of exogenous factors and systemic diseases leading to male...
Выпуск №1 за 2020 год
Introduction. Bladdercancer (BC) represents one of the most frequent disease in the structure of morbidity and mortality among malignant neoplasms in human. At the moment, there is a large amount of...
Выпуск №2 за 2016 год
Relevance. PCA3 demonstrated a high diagnostic value in relation to prostate cancer. The few studies of clinical and cost-effectiveness of PCA3 dedicated to costly test "Progensa". Economic...
Выпуск №4 за 2015 год
More than 13 thousand cases of
bladder cancer are registered in
Russia annually that represents an actual
problem in modern urologic oncology.
Searching and characterization of
new molecular markers...
Выпуск №2 за 2015 год
Over the past 20 years a large number of prostate cancer (PCa) markers have been proposed. A combination of PCA3 and TMPRSS2-ERG is among them. The real-time RT-PCRbased method for РСА3 and TMPRSS2-...
Выпуск №3 за 2014 год
More than 20-years experience of PSA
use for PCa screening has lead to a life
expectancy growth and reduction of
mortality in PCa patients. On the other
side, widespread use of PSA resulted in
some...
Выпуск №3 за 2013 год
Renal cancer is a heterogeneous group of
tumors, the most common of which is the
clear cell carcinoma, less common papillary
and chromophobe carcinomas. Pathological
examination faces difficulties...